BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24222137)

  • 21. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ORAOV1 is amplified in oral squamous cell carcinoma.
    Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
    J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
    Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y
    Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
    Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
    Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.
    Hu J; Ge W; Xu J
    Tumour Biol; 2016 Jul; 37(7):9433-40. PubMed ID: 26781875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surrounding cells affect the gene expression pattern of human beta-defensins in squamous cell carcinoma in vitro.
    Kida-Takaoka S; Yamaai T; Mizukawa N; Murakami J; Iida S
    Anticancer Res; 2014 Nov; 34(11):6443-9. PubMed ID: 25368244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
    Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
    J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins.
    Hoppe T; Kraus D; Novak N; Probstmeier R; Frentzen M; Wenghoefer M; Jepsen S; Winter J
    Tumour Biol; 2016 Oct; 37(10):13789-13798. PubMed ID: 27481514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
    Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
    Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
    Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
    Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.
    Yamamoto A; Kasamatsu A; Ishige S; Koike K; Saito K; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):533-42. PubMed ID: 23207790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
    Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
    Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma.
    Liu Z; Tao H
    J Cell Biochem; 2020 Mar; 121(3):2150-2158. PubMed ID: 31762107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.
    Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF
    Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
    Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
    J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.
    Oka R; Nakashiro K; Goda H; Iwamoto K; Tokuzen N; Hamakawa H
    Oncotarget; 2016 Jan; 7(4):4882-9. PubMed ID: 26700817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.
    Alam H; Gangadaran P; Bhate AV; Chaukar DA; Sawant SS; Tiwari R; Bobade J; Kannan S; D'cruz AK; Kane S; Vaidya MM
    PLoS One; 2011; 6(11):e27767. PubMed ID: 22114688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.